Locked nucleic acid holds promise in the treatment of cancer.

Frieden, Miriam; Ørum, Henrik

Frieden, Miriam; Ørum, Henrik.

Affiliation

Frieden M; Santaris Pharma, Bøge Allé 5, Hørsholm-2970, DK, Denmark. mfr@santaris.com

Curr Pharm Des ; 14(11): 1138-42, 2008.

Article in En | MEDLINE | ID: mdl-18473860

Subject(s)

Antineoplastic Agents/pharmacology; Neoplasms/drug therapy; Oligonucleotides/pharmacology; Animals; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Clinical Trials as Topic; Drug Delivery Systems; Humans; Oligonucleotides/adverse effects; Oligonucleotides/therapeutic use; Oligonucleotides, Antisense/adverse effects; Oligonucleotides, Antisense/pharmacology; Oligonucleotides, Antisense/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2008 Document type: Article Affiliation country: Denmark

Search on Google

Add to My VHL

XML

PubMed Links